和元生物: 《和元生物技术（上海）股份有限公司2025年限制性股票激励计划（草案）》

Core Points - The company has proposed a 2025 Restricted Stock Incentive Plan, which aims to enhance the long-term incentive mechanism and align the interests of shareholders, the company, and core team members [8][9][30] - The plan intends to grant a total of 3,745,400 restricted shares, accounting for approximately 0.58% of the company's total share capital as of the announcement date [2][19] - The initial grant will be distributed among 61 individuals, primarily including directors, senior management, and key technical and business personnel [3][13] Summary by Sections Incentive Plan Overview - The incentive plan is based on various legal frameworks, including the Company Law and Securities Law of the People's Republic of China [1] - The plan will utilize restricted stock as the incentive method, sourced from the company's repurchased A-shares [1][2] Grant Conditions - The initial grant price for the restricted shares is set at 3.09 yuan per share, with adjustments possible based on corporate actions [5][23] - The plan's effective period is from the grant date until all shares are vested or become void, lasting no more than 36 months [6][7] Eligible Participants - The plan targets 61 individuals, representing about 8.82% of the total workforce, excluding independent directors and major shareholders [3][13] - The eligibility criteria for participants include holding a labor or service relationship with the company during the grant and assessment periods [13][14] Performance and Vesting Conditions - Vesting of the restricted shares will occur in two phases, with 50% vesting after 12 months and the remaining 50% after 24 months, contingent on meeting performance targets [21][25] - The performance targets are based on the company's revenue growth rates for the fiscal years 2025 and 2026, with specific thresholds set for vesting [30][31] Management and Oversight - The company's board of directors and the remuneration and assessment committee will oversee the implementation and management of the incentive plan [11][12] - Any changes to the plan must be approved by the shareholders' meeting, ensuring compliance with relevant regulations [12][14] Adjustments and Compliance - The plan includes provisions for adjusting the number of restricted shares in response to corporate actions such as stock splits or dividends [30] - The company commits not to provide financial assistance to participants for purchasing the restricted shares [6][7]